Here are five most-read stories this year:
1. 91 patients treated for TB after spine surgery with infected allograft
2. Bioventus to acquire spine company for $518M
3. Stem cell sales skyrocket despite lacking FDA approval, study finds
4. Medtronic terminates deal to distribute Aziyo’s cellular bone matrix products
5. Regenerative implant for lumbar spine surgery gets FDA breakthrough designation
